Skip to content
Back to Guavy Wire
Stocks

Erste Group Bank Lowers Earnings Estimates for Amgen Amid Recent Upgrades

Instruments
AMGN
Share

Erste Group Bank has lowered its earnings estimates for Amgen Inc. (NASDAQ:AMGN) in a research report issued on August 5th. Analyst H. Engel now expects the medical research company to post earnings of $23.50 per share for FY2027, down from their previous estimate of $23.58.

The consensus estimate for Amgen's current full-year earnings is $22.78 per share. Despite this adjustment, several other analysts have raised their price targets and ratings on the stock. Weiss Ratings upgraded Amgen to a 'buy' rating in a recent research note, while Oppenheimer boosted its price objective from $400 to $450.

Amgen's latest quarterly earnings report exceeded expectations, with revenue of approximately $10.05 billion, up 9.5% year over year, and adjusted earnings of $6.29 per share surpassing the $5.62 consensus estimate.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc